Contemplating the Future of List Prices
October 25, 2019
What execs and experts think of the future of drug costs.
Direct and concise information will dissuade dangerous use.
Health System News
FDA, FTC Issue More CBD Manufacturer Warnings
October 24, 2019
Fifth company warned about unsubstantiated claims this year.
FDA Approves Biophen for Hypotension in Anesthesia Settings
October 24, 2019
New formulation improves safety for patients.
New Drug Review: Tafamidis Meglumine for Cardiomyopathy
October 24, 2019
Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
FDA Approves Mealtime Insulin for Use with Infusion Pumps
October 23, 2019
Previously approved for IV infusion.
Ustekinumab Gains FDA Approval as Ulcerative Colitis Treatment
October 23, 2019
Fourth indication expansion for the 2009 drug.
Life-Altering Gene Therapy Pipeline Poses Challenges
October 23, 2019
What to expect for these high-dollar drugs.
Dapagliflozin Approved to Reduce Hospitalization in Diabetes Patients
October 22, 2019
Reduces risk for heart failure and cardiovascular disease hospitalizations.
FDA Approves Triple Combination Therapy for Cystic Fibrosis
October 22, 2019
Drug able to treat 18,000 people will cost over $300k per year.
Solving the Drug Shortage Burden
October 22, 2019
Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.
